A quantitative method for detection of circulating fms related tyrosine kinase 3 (FLT-3) in acute myeloid leukemia (AML) patients
- 1 July 2019
- journal article
- research article
- Published by Elsevier in Journal of Immunological Methods
- Vol. 470, 55-58
Abstract
No abstract availableKeywords
This publication has 6 references indexed in Scilit:
- Midostaurin approved for FLT3-mutated AMLBlood, 2017
- Survival Outcomes in Patients with FLT3-Itd Positive Acute Myeloid Leukaemia Relative to Biological Stratification: Smaller FLT3-Itd Clone Size Predict Better Overall SurvivalBlood, 2012
- Downstream molecular pathways of FLT3 in the pathogenesis of acute myeloid leukemia: biology and therapeutic implicationsJournal of Hematology & Oncology, 2011
- The roles of FLT3 in hematopoiesis and leukemiaBlood, 2002
- THE FIFTH IMMUNOGLOBULIN-LIKE DOMAIN OF THE KIT RECEPTOR IS REQUIRED FOR PROTEOLYTIC CLEAVAGE FROM THE CELL SURFACECytokine, 2001
- TNF-α-Converting Enzyme Cleaves the Macrophage Colony-Stimulating Factor Receptor in Macrophages Undergoing ActivationThe Journal of Immunology, 2001